A National Research Priority Program of  
the

Logo der Deutschen Forschungsgesellschaft

Pressemitteilung Uniklinik Köln, März 2012

Höhere Anfälligkeit für Schizophrenie bei Rauchern

Rauchen verändert die Wirkung eines Schizophrenie-Risikogens.
Wissenschaftler der Uniklinik Köln und der Universität Zürich
zeigen: Gesunde Menschen, die dieses Risikogen tragen und
rauchen, verarbeiten akustische Reize ähnlich schlecht wie
Patienten mit einer Schizophrenie. Dabei ist der Effekt umso stärker,
je mehr die Betroffenen rauchen.

read more..

 

 

 

 

Projects

P24 Towards risk prediction of nicotine dependency by exploring individual limits of cortical neuroplasticity in humans

Funding Period 2007 - 2010

P24

Towards risk prediction of nicotine dependency by exploring individual limits of cortical neuroplasticity in humans

Dr. Michael Nitsche (Principle Investigator)
University of Goettingen
Dept. of Clinical Neurophysiology
Robert-Koch-Strasse 40, 37075 Goettingen
+49-(0)551/39-12631
This e-mail address is being protected from spambots. You need JavaScript enabled to view it.

together with:

Dr. Nicolas Lang
University of Goettingen
Dept. of Clinical Neurophysiology
Robert-Koch-Strasse 40, 37075 Goettingen
+49-(0)551/39-8457
This e-mail address is being protected from spambots. You need JavaScript enabled to view it.

Professor Dr. Walter Paulus
University of Goettingen
Dept. of Clinical Neurophysiology
Robert-Koch-Strasse 40, 37075 Goettingen
+49-(0)551/39-6650
This e-mail address is being protected from spambots. You need JavaScript enabled to view it.

Nicotine is a strong inductor and modulator of cortical activity and long-term potentiation. Hereby it influences learning and memory processes as well as addiction. Nicotine-dependent cognitive improvements in humans seem to differ between smoking and not smoking individuals, as presumed by the "deficit compensating hypothesis" of nicotine consumption. This project pursues the following aims: (i) First we will differentiate acute cortical excitability shifts elicited by nicotine in smokers and non-smokers (Collaboration with Prof. Wodarz). (ii) We will induce LTPand LTD-like cortical neuroplasticity changes by transcranial direct current stimulation with and without nicotine in smokers and non-smokers, (iii) We will correlate nicotineenhanced neuroplasticity with cognitive performance and performance-related cerebral activity, as revealed by fMRI, in smokers and non-smokers, (iv) The interdependence of neurophysiological and cognitive effects with genetically defined phenotypes (collaboration with Proff. Winterer, Batra, Andreas) of smokers will be explored. In summary, we aim to develop a neurophysiology-based in vivo model of the impact of nicotine on cerebral function, which will help to understand the mechanisms of nicotine addiction and relapse after withdrawal to a greater extent.



© Cologne Center for Genomics 2012 webdesign: blickpunkt |x|